COMMUNIQUÉS West-GlobeNewswire

Kommuniké från årsstämman i LIDDS
16/05/2019
Den 16 maj 2019 hölls årsstämma i LIDDS AB (publ). Nedan följer sammanfattning av de beslut som fattades. Beslut fattades med erforderlig majoritet . Vid stämman var 433 852 (1,88%) av totalt 23 051 188 aktier [...]
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837
16/05/2019
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837 Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic candidate DNV3837 in [...]
SuperSonic Imagine Resolves Legal Disputes with Verasonics
16/05/2019
AIX-EN-PROVENCE, France, May 16, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specializing in ultrasound medical imaging (diagnostic ultrasound), announced today that it has [...]
Spineway : Acquisition confirmed for Latin America and Africa
16/05/2019
Acquisition confirmed for Latin America and Africa SPINEWAY announces that the conditions precedent have been met and confirms its acquisition of an equity stake in INTEGRAL MEDICAL SOLUTIONS (IMS), a holding company at [...]
SPINEWAY : Prise de participation confirmée en Amérique Latine et en Afrique
16/05/2019
Prise de participation confirmée en Amérique Latine et en Afrique SPINEWAY annonce la levée des conditions suspensives et confirme sa prise de participation au capital d’INTEGRAL MEDICAL SOLUTIONS (IMS), société holding [...]
REACH Air Medical Services Adding Guardian Flight to Company Operations
16/05/2019
Integration Will Result in Increased Service and Enhanced Care for Patients & Communities Sacramento, CA. and South Jordan, UT., May 16, 2019 (GLOBE NEWSWIRE) -- REACH Air Medical Services (REACH) today announced [...]
Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association
16/05/2019
SAN DIEGO and TORONTO, May 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the [...]
BBS reinforces the management team with the appointment of Paul Watkins as a Chief Commercial Officer
16/05/2019
BBS – Bioactive Bone Substitutes, an innovator in orthobiologics, today announced the appointment of Paul Watkins to the newly created position of Chief Commercial Officer. With more than 30 years in the field, Paul has [...]
Biothera Pharmaceuticals to Present Clinical Data from Phase 2 Triple Negative Breast Cancer Study at ASCO 2019 Annual Meeting
16/05/2019
Study Evaluating Combination of Biothera’s Imprime PGG and Merck’s KEYTRUDA® EAGAN, Minn., May 16, 2019 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc., which is developing a dectin receptor agonist drug known as [...]
STARS announces first all-female lineup for 2019 Rescue in the Rockies
16/05/2019
Prominent corporate and community leaders will be airlifted to a remote location in the Rockies for annual STARS fundraiser CALGARY, Alberta, May 16, 2019 (GLOBE NEWSWIRE) -- The Shock Trauma Air Rescue Service ( STARS [...]
Genmab Announces Data to be Presented at 24th EHA Annual Congress
16/05/2019
Media Release Copenhagen, Denmark, May 16, 2019 15 industry-sponsored abstracts featuring Genmab programs selected for presentation at EHA Annual Congress Genmab A/S (Nasdaq Copenhagen: GEN) announced today that 15 [...]
TOMI Environmental Solutions, Inc. Partnership With CleanCor Technologies Receives Registration From The Ministry of Health in the State of Israel
16/05/2019
BEVERLY HILLS, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination utilizes its premier Binary [...]
Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis
16/05/2019
BEVERLY, Mass., May 16, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has signed a non-binding term [...]
Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases
16/05/2019
FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons DUBLIN - May 16, 2019 - Medtronic plc (NYSE:MDT), a global leader in [...]
Corline Biomedical AB: Will present at investor event hosted by Aktiespararna on June 3rd in Stockholm
16/05/2019
The investor event will be held at the Sheraton Hotel in Stockholm. Corline will present at 08:40 in the morning of June 3rd. For more information on the event and how to follow Corline's presentaiton, please refer to: [...]
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress
16/05/2019
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that two abstracts containing clinical data and analyses related to imetelstat, the Company’s first-in-class [...]
GBT Announces Upcoming Data Presentations at 24th European Hematology Association (EHA) Congress Supporting Voxelotor Sickle Cell Disease Program
16/05/2019
Phase 3 HOPE Study 24-Week Efficacy Results from Full Patient Cohort to be Presented During Presidential Symposium New Drug Application (NDA) Submission Planned for Voxelotor to Include HOPE Study Data Being Presented [...]
INmune Bio Announces Common Stock Purchase Agreement for up to $20.0 Million with Lincoln Park Capital
16/05/2019
LA JOLLA, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Forty Seven, Inc. to Present Updated Data from Ongoing Phase 1b/2 Clinical Trial of 5F9 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma at 24th Congress of the European Hematology Association
16/05/2019
MENLO PARK, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc., a clinical-stage immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that [...]

Pages